Project Grant 2451680

Award Date 7/15/25
Completion Date 6/30/26
Dollars Obligated $305K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Dorchester, MA 02125, USA
Similar Awards
This $280,000 Project Grant award from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program supports the development of comprehensive generative AI methodologies and computational tools to expedite drug discovery, enhance cost efficiency, and improve success rates. The project aims to create a holistic generative AI framework capable of generating high-quality drug candidates with multiple desired properties, with the potential to transform...
This $274,797 National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Deepseq.ai LLC supports the development of an AI-driven platform to accelerate the identification of highly developable single-domain antibodies for drug discovery. The proposed work aims to create a multimodal AI model capable of rapidly screening large libraries to generate lead molecules with favorable binding affinity, stability, and manufacturability. This project...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Om Therapeutics Inc. will support the development of a system to enable the rapid, scalable, and cost-effective discovery of new medicines using machine learning. The project aims to encapsulate proteins and small molecules in millions of miniaturized compartments to screen for interactions that could identify novel drug candidates. The key innovations include...
This Project Grant award from the National Science Foundation (CFDA 47.070 - Computer and Information Science and Engineering) to the Regents of the University of Minnesota will provide $220,000 to develop advanced generative AI methodologies and computational tools to expedite drug discovery and enhance cost efficiency. The key objectives are to create a holistic generative AI framework capable of generating high-quality drug candidates with multiple desired properties, as well as a direct...
This $100,000 Project Grant awarded by the National Science Foundation (NSF) under the Biological Sciences (CFDA 47.074) program aims to accelerate protein engineering through the integration of cutting-edge artificial intelligence (AI) methods and advanced laboratory automation. The primary objectives are to develop new AI techniques tailored to the unique challenges of protein engineering, and to leverage these AI capabilities to guide the design and discovery of functional proteins with...
This Project Grant award of $233,332 from the National Science Foundation's (NSF) Computer and Information Science and Engineering (CISE) program will support collaborative research to accelerate protein engineering using evolution-guided generative AI and an automated biofoundry. The research aims to combine cutting-edge AI methods with advanced laboratory automation to greatly speed up the discovery of new proteins with enhanced properties, offering significant potential impact across...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $303,864 to Core Biotherapeutics Inc. to develop a platform for discovering therapeutic drugs that can reprogram molecular networks to treat diseases. The project aims to determine the biological laws driving diseases at the molecular network level and create an algorithm to rapidly identify drug targets. The key goals are to demonstrate that oligonucleotide drug...
This Project Grant award from the National Science Foundation (NSF) Division of Information and Intelligent Systems (CFDA #47.070 - Computer and Information Science and Engineering) provides $599,939 to Texas A&M Engineering Experiment Station (Tees) to develop novel 3D graph neural network algorithms and architectures. The key objectives are to (1) create 3D graph neural networks that can efficiently and accurately capture the geometric properties of small molecules and proteins to generate...
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, supports the development of an AI-enabled toolkit for optimizing combination drug research and development. The $264,736 award to Duet Biosystems, Inc. in Nashville, TN aims to leverage the Multidimensional Synergies of Combination (MUSYC) algorithm to improve the selection of effective drug combinations across disease areas such as cancer,...
This $100,000 Project Grant award from the National Science Foundation's (NSF) Biological Sciences (CFDA 47.074) Federal Grant Program supports the development of deep learning-based "consistency models" to simulate the long-time-scale dynamics of protein structures. The project aims to overcome the limitations of traditional molecular dynamics (MD) simulations, which are constrained by small time steps and unable to capture crucial long-duration protein behaviors like folding and...

This Project Grant award of $305,000.00 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to revolutionize drug discovery by accelerating molecular dynamics simulations through advanced AI techniques. The project, awarded to Giwotech Inc. in Dorchester, MA, seeks to develop a robust neural network model capable of simulating protein systems up to 500 times faster than current GPU-based classical molecular dynamic simulators while maintaining accuracy and stability. The anticipated technical results include a platform that significantly accelerates drug discovery processes, enabling the exploration of rare molecular events and complex biological systems. This has the potential to reduce drug development timelines by 2-5 years, cut costs by $300 million to $1 billion per approved drug, and increase clinical trial success rates by 20-30%. Subawards are planned for this project.

Generated 8/5/25, 4:43 AM